LYTIR

Company · IAM

Iambic Therapeutics, Inc.

Nasdaq's symbol directory lists IAM on Nasdaq as “Iambic Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($11.5M); 1 filing by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 52

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Rachlin Evan Lockwood bought on 1 day latest Oct 16, 2026 bought $11.5M
Every trade (1)
  1. BUYRachlin Evan Lockwood bought Oct 16, 2026 718,750 shares filing $11.5M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Qatar Investment Authority filed Nov 9, 2026 Schedule 13G passive 2,804,360 shares filing 5.8%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 16, 2026
  2. Amendments to articles or bylaws; change in fiscal year; Regulation FD disclosure filing Oct 16, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.